Clene (CLNN) CFO gets 35,000 options at $5.42, vesting immediately

Rhea-AI Filing Summary

Clene Inc.'s Chief Financial Officer received a new stock option grant. On January 22, 2026, CFO Morgan R. Brown was granted a stock option covering 35,000 shares of Clene Inc. common stock under the company’s Amended 2020 Stock Plan. The option has an exercise price of $5.42 per share and is reported as held directly. According to the disclosure, the options vest immediately upon grant, meaning they are fully exercisable from the grant date, and following this transaction the reporting person beneficially owns 35,000 derivative securities tied to common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BROWN MORGAN R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	stock option	35,000	$0.00	--

Holdings After Transaction: stock option — 35,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROWN MORGAN R

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$5.42	01/22/2026		A		35,000		(1)	01/21/2036	common stock	35,000	$0	35,000	D

Explanation of Responses:

1. This option was granted on January 22, 2026 as an option for 35,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clene (CLNN) report in this Form 4?

The filing reports that Clene Inc.'s Chief Financial Officer, Morgan R. Brown, was granted a stock option for 35,000 shares of common stock on January 22, 2026.

What are the key terms of the Clene (CLNN) CFO’s stock option grant?

The CFO’s stock option covers 35,000 shares of Clene common stock with an exercise price of $5.42 per share and vests immediately upon grant.

Is the Clene (CLNN) CFO’s stock option held directly or indirectly?

The Form 4 states that the 35,000 stock options are held with direct ownership by the reporting person.

When do the newly granted Clene (CLNN) stock options expire?

The stock option granted to the CFO on January 22, 2026 has an expiration date of January 21, 2036.

How many derivative securities does the Clene (CLNN) CFO own after this grant?

Following the reported transaction, the CFO beneficially owns 35,000 derivative securities in the form of stock options tied to Clene common stock.

Was this Clene (CLNN) Form 4 transaction a grant or a sale by the CFO?

The transaction is coded as A (acquired) and reflects a grant of stock options to the CFO, not a sale of existing shares.